» Articles » PMID: 19891905

A Modern Approach to the Treatment of Mitochondrial Disease

Overview
Specialty Neurology
Date 2009 Nov 7
PMID 19891905
Citations 141
Authors
Affiliations
Soon will be listed here.
Abstract

The treatment of mitochondrial disease varies considerably. Most experts use a combination of vitamins, optimize patients' nutrition and general health, and prevent worsening of symptoms during times of illness and physiologic stress. We agree with this approach, and we agree that therapies using vitamins and cofactors have value, though there is debate about the choice of these agents and the doses prescribed. Despite the paucity of high-quality scientific evidence, these therapies are relatively harmless, may alleviate select clinical symptoms, and theoretically may offer a means of staving off disease progression. Like many other mitochondrial medicine physicians, we have observed significant (and at times life-altering) clinical responses to such pharmacologic interventions. However, it is not yet proven that these therapies truly alter the course of the disease, and some experts may choose not to use these medications at all. At present, the evidence of their effectiveness does not rise to the level required for universal use. Based on our clinical experience and judgment, however, we agree that a therapeutic trial of coenzyme Q10, along with other antioxidants, should be attempted. Although individual specialists differ as to the exact drug cocktail, a common approach involves combinations of antioxidants that may have a synergistic effect. Because almost all relevant therapies are classified as medical foods or over-the-counter supplements, most physicians also attempt to balance the apparent clinical benefit of mitochondrial cocktails with the cost burden that these supplements pose for the family.

Citing Articles

Clinical and Genetic Insights Into Combined Oxidative Phosphorylation Defect Type 38.

Yadav B, Bhattarai C, Singh S, Basnet K, Gupta A, Khan S Clin Case Rep. 2025; 13(3):e70273.

PMID: 40018422 PMC: 11865325. DOI: 10.1002/ccr3.70273.


Anaesthesia Management of a Pregnant Woman with Glutaric Aciduria Type 1 Undergoing Cesarean Section.

Demirel Y, Kesici S, Kaya C, Oba S, Turk H Turk J Anaesthesiol Reanim. 2025; 53(1):28-30.

PMID: 39932066 PMC: 11827511. DOI: 10.4274/TJAR.2025.241705.


Current global vitamin and cofactor prescribing practices for primary mitochondrial diseases: Results of a European reference network survey.

Neugebauer J, Reinson K, Bellusci M, Park J, Hikmat O, Bertini E J Inherit Metab Dis. 2024; 48(1):e12805.

PMID: 39529390 PMC: 11670042. DOI: 10.1002/jimd.12805.


Balancing Anesthesia in a Child With Mitochondrial Disease: A Case Report.

Manickam A, Fathima K, Bagri V, Ganesh Prabu A, R V Cureus. 2024; 16(10):e70756.

PMID: 39493163 PMC: 11531197. DOI: 10.7759/cureus.70756.


Emerging Multi-omic Approaches to the Molecular Diagnosis of Mitochondrial Disease and Available Strategies for Treatment and Prevention.

Khaghani F, Hemmati M, Ebrahimi M, Salmaninejad A Curr Genomics. 2024; 25(5):358-379.

PMID: 39323625 PMC: 11420563. DOI: 10.2174/0113892029308327240612110334.


References
1.
Marriage B, Clandinin M, MacDonald I, Glerum D . Cofactor treatment improves ATP synthetic capacity in patients with oxidative phosphorylation disorders. Mol Genet Metab. 2004; 81(4):263-72. DOI: 10.1016/j.ymgme.2003.12.008. View

2.
Wenz T, Diaz F, Spiegelman B, Moraes C . Activation of the PPAR/PGC-1alpha pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype. Cell Metab. 2008; 8(3):249-56. PMC: 2613643. DOI: 10.1016/j.cmet.2008.07.006. View

3.
Bernsen P, Gabreels F, Ruitenbeek W, Hamburger H . Treatment of complex I deficiency with riboflavin. J Neurol Sci. 1993; 118(2):181-7. DOI: 10.1016/0022-510x(93)90108-b. View

4.
Fischel-Ghodsian N . Genetic factors in aminoglycoside toxicity. Ann N Y Acad Sci. 2000; 884:99-109. DOI: 10.1111/j.1749-6632.1999.tb08639.x. View

5.
Freeman J, Vining E, Kossoff E, Pyzik P, Ye X, Goodman S . A blinded, crossover study of the efficacy of the ketogenic diet. Epilepsia. 2008; 50(2):322-5. DOI: 10.1111/j.1528-1167.2008.01740.x. View